v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Total revenues $ 36,769 $ 18,385 $ 80,253 $ 48,023
Costs and operating expenses:        
Cost of product revenue 6,867 3,642 15,403 7,882
Research and development 15,165 12,010 39,562 33,830
Selling, general and administrative 13,407 8,797 37,600 26,307
Total costs and operating expenses 35,439 24,449 92,565 68,019
Income (loss) from operations 1,330 (6,064) (12,312) (19,996)
Interest income 41 39 424 362
Other income (expense), net 983 (50) 920 (125)
Income (loss) before income taxes 2,354 (6,075) (10,968) (19,759)
Provision for income taxes 110 19 121 331
Net income (loss) $ 2,244 $ (6,094) $ (11,089) $ (20,090)
Net income (loss) per share, basic (in usd per share) $ 0.03 $ (0.10) $ (0.17) $ (0.34)
Net income (loss) per share, diluted (in usd per share) $ 0.03 $ (0.10) $ (0.17) $ (0.34)
Weighted average common stock shares used in computing net income (loss) per share, basic (in shares) 64,628 59,061 64,452 58,984
Weighted average common stock shares used in computing net income (loss) per share, diluted (in shares) 67,741 59,061 64,452 58,984
Product revenue        
Revenues:        
Total revenues $ 28,731 $ 8,401 $ 53,674 $ 18,005
Research and development revenue        
Revenues:        
Total revenues $ 8,038 $ 9,984 $ 26,579 $ 30,018

Source